midazolam and lcl161
midazolam has been researched along with lcl161 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Cameron, S; Dhuria, S; Einolf, H; Gu, H; Mangold, J; Sen, S; Wang, L | 1 |
Other Studies
1 other study(ies) available for midazolam and lcl161
| Article | Year |
|---|---|
Time-dependent inhibition and induction of human cytochrome P4503A4/5 by an oral IAP antagonist, LCL161, in vitro and in vivo in healthy subjects.
Topics: Adult; Area Under Curve; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Female; Hepatocytes; Humans; Inhibitor of Apoptosis Proteins; Male; Microsomes, Liver; Midazolam; Middle Aged; Models, Biological; Pregnane X Receptor; Receptors, Steroid; RNA, Messenger; Thiazoles; Time Factors; Young Adult | 2013 |